Selected research
Industry Research
Computational Toxicology Platform Industry Research Report 2026
Market perspective
The global Computational Toxicology Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Computational Toxicology Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Computational Toxicology Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Computational Toxicology Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Computational Toxicology Platform include Simulations Plus, Lhasa, Instem, Elsevier, Clarivate, ACD/Labs, Optibrium, MultiCASE and Chemical Computing Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Computational Toxicology Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Computational Toxicology Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Computational Toxicology Platform Market by Company
Simulations Plus
Lhasa
Instem
Elsevier
Clarivate
ACD/Labs
Optibrium
MultiCASE
Chemical Computing Group
Molecular Networks
ProtoQSAR
KREATiS
Certara
Dassault Systèmes
Schrödinger
Computational Toxicology Platform Segment by Type
Cloud-Based Platform
On-Premises Software
Hybrid Deployment
Computational Toxicology Platform Segment by Application
Pharmaceutical and Biotechnology
Chemicals and Materials
Agrochemicals
Cosmetics and Consumer Products
Government and Regulatory Agencies
Academic and Contract Research
Computational Toxicology Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Toxicology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Computational Toxicology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Toxicology Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Computational Toxicology Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based Platform
- On-Premises Software
- Hybrid Deployment
Applications
- Pharmaceutical and Biotechnology
- Chemicals and Materials
- Agrochemicals
- Cosmetics and Consumer Products
- Government and Regulatory Agencies
- Academic and Contract Research
Companies covered
- Simulations Plus
- Lhasa
- Instem
- Elsevier
- Clarivate
- ACD/Labs
- Optibrium
- MultiCASE
- Chemical Computing Group
- Molecular Networks
- ProtoQSAR
- KREATiS
- Certara
- Dassault Systèmes
- Schrödinger
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Computational Toxicology Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-Based Platform
- 2.2.3 On-Premises Software
- 2.2.4 Hybrid Deployment
- 2.3 Computational Toxicology Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology
- 2.3.3 Chemicals and Materials
- 2.3.4 Agrochemicals
- 2.3.5 Cosmetics and Consumer Products
- 2.3.6 Government and Regulatory Agencies
- 2.3.7 Academic and Contract Research
- 2.4 Assumptions and Limitations
3 Computational Toxicology Platform Breakdown Data by Type
- 3.1 Global Computational Toxicology Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Computational Toxicology Platform Forecasted Market Size by Type (2027-2032)
4 Computational Toxicology Platform Breakdown Data by Application
- 4.1 Global Computational Toxicology Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Computational Toxicology Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Computational Toxicology Platform Market Perspective (2021-2032)
- 5.2 Global Computational Toxicology Platform Growth Trends by Region
- 5.2.1 Global Computational Toxicology Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Computational Toxicology Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Computational Toxicology Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Computational Toxicology Platform Market Dynamics
- 5.3.1 Computational Toxicology Platform Industry Trends
- 5.3.2 Computational Toxicology Platform Market Drivers
- 5.3.3 Computational Toxicology Platform Market Challenges
- 5.3.4 Computational Toxicology Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Computational Toxicology Platform Players by Revenue
- 6.1.1 Global Top Computational Toxicology Platform Players by Revenue (2021-2026)
- 6.1.2 Global Computational Toxicology Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Computational Toxicology Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Computational Toxicology Platform Head Office and Area Served
- 6.4 Global Computational Toxicology Platform Players, Product Type & Application
- 6.5 Global Computational Toxicology Platform Manufacturers Established Date
- 6.6 Global Computational Toxicology Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Computational Toxicology Platform Market Size (2021-2032)
- 7.2 North America Computational Toxicology Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Computational Toxicology Platform Market Size by Country (2021-2026)
- 7.4 North America Computational Toxicology Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Computational Toxicology Platform Market Size (2021-2032)
- 8.2 Europe Computational Toxicology Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Computational Toxicology Platform Market Size by Country (2021-2026)
- 8.4 Europe Computational Toxicology Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Computational Toxicology Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Computational Toxicology Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Computational Toxicology Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Computational Toxicology Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Computational Toxicology Platform Market Size (2021-2032)
- 10.2 South America Computational Toxicology Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Computational Toxicology Platform Market Size by Country (2021-2026)
- 10.4 South America Computational Toxicology Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Computational Toxicology Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Computational Toxicology Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Computational Toxicology Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Computational Toxicology Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Simulations Plus
- 12.1.1 Simulations Plus Company Information
- 12.1.2 Simulations Plus Business Overview
- 12.1.3 Simulations Plus Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.1.4 Simulations Plus Computational Toxicology Platform Product Portfolio
- 12.1.5 Simulations Plus Recent Developments
- 12.2 Lhasa
- 12.2.1 Lhasa Company Information
- 12.2.2 Lhasa Business Overview
- 12.2.3 Lhasa Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.2.4 Lhasa Computational Toxicology Platform Product Portfolio
- 12.2.5 Lhasa Recent Developments
- 12.3 Instem
- 12.3.1 Instem Company Information
- 12.3.2 Instem Business Overview
- 12.3.3 Instem Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.3.4 Instem Computational Toxicology Platform Product Portfolio
- 12.3.5 Instem Recent Developments
- 12.4 Elsevier
- 12.4.1 Elsevier Company Information
- 12.4.2 Elsevier Business Overview
- 12.4.3 Elsevier Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.4.4 Elsevier Computational Toxicology Platform Product Portfolio
- 12.4.5 Elsevier Recent Developments
- 12.5 Clarivate
- 12.5.1 Clarivate Company Information
- 12.5.2 Clarivate Business Overview
- 12.5.3 Clarivate Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.5.4 Clarivate Computational Toxicology Platform Product Portfolio
- 12.5.5 Clarivate Recent Developments
- 12.6 ACD/Labs
- 12.6.1 ACD/Labs Company Information
- 12.6.2 ACD/Labs Business Overview
- 12.6.3 ACD/Labs Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.6.4 ACD/Labs Computational Toxicology Platform Product Portfolio
- 12.6.5 ACD/Labs Recent Developments
- 12.7 Optibrium
- 12.7.1 Optibrium Company Information
- 12.7.2 Optibrium Business Overview
- 12.7.3 Optibrium Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.7.4 Optibrium Computational Toxicology Platform Product Portfolio
- 12.7.5 Optibrium Recent Developments
- 12.8 MultiCASE
- 12.8.1 MultiCASE Company Information
- 12.8.2 MultiCASE Business Overview
- 12.8.3 MultiCASE Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.8.4 MultiCASE Computational Toxicology Platform Product Portfolio
- 12.8.5 MultiCASE Recent Developments
- 12.9 Chemical Computing Group
- 12.9.1 Chemical Computing Group Company Information
- 12.9.2 Chemical Computing Group Business Overview
- 12.9.3 Chemical Computing Group Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.9.4 Chemical Computing Group Computational Toxicology Platform Product Portfolio
- 12.9.5 Chemical Computing Group Recent Developments
- 12.10 Molecular Networks
- 12.10.1 Molecular Networks Company Information
- 12.10.2 Molecular Networks Business Overview
- 12.10.3 Molecular Networks Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.10.4 Molecular Networks Computational Toxicology Platform Product Portfolio
- 12.10.5 Molecular Networks Recent Developments
- 12.11 ProtoQSAR
- 12.11.1 ProtoQSAR Company Information
- 12.11.2 ProtoQSAR Business Overview
- 12.11.3 ProtoQSAR Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.11.4 ProtoQSAR Computational Toxicology Platform Product Portfolio
- 12.11.5 ProtoQSAR Recent Developments
- 12.12 KREATiS
- 12.12.1 KREATiS Company Information
- 12.12.2 KREATiS Business Overview
- 12.12.3 KREATiS Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.12.4 KREATiS Computational Toxicology Platform Product Portfolio
- 12.12.5 KREATiS Recent Developments
- 12.13 Certara
- 12.13.1 Certara Company Information
- 12.13.2 Certara Business Overview
- 12.13.3 Certara Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.13.4 Certara Computational Toxicology Platform Product Portfolio
- 12.13.5 Certara Recent Developments
- 12.14 Dassault Systèmes
- 12.14.1 Dassault Systèmes Company Information
- 12.14.2 Dassault Systèmes Business Overview
- 12.14.3 Dassault Systèmes Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.14.4 Dassault Systèmes Computational Toxicology Platform Product Portfolio
- 12.14.5 Dassault Systèmes Recent Developments
- 12.15 Schrödinger
- 12.15.1 Schrödinger Company Information
- 12.15.2 Schrödinger Business Overview
- 12.15.3 Schrödinger Revenue in Computational Toxicology Platform Business (2021-2026)
- 12.15.4 Schrödinger Computational Toxicology Platform Product Portfolio
- 12.15.5 Schrödinger Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst